263 related articles for article (PubMed ID: 24016602)
21. Gain-of-Function Dynamin-2 Mutations Linked to Centronuclear Myopathy Impair Ca
Bayonés L; Guerra-Fernández MJ; Hinostroza F; Báez-Matus X; Vásquez-Navarrete J; Gallo LI; Parra S; Martínez AD; González-Jamett A; Marengo FD; Cárdenas AM
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142275
[TBL] [Abstract][Full Text] [Related]
22. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
[TBL] [Abstract][Full Text] [Related]
23. DNM2 mutations in Chinese Han patients with centronuclear myopathy.
Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C
Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122
[TBL] [Abstract][Full Text] [Related]
24. Dynamin-2 R465W mutation induces long range perturbation in highly ordered oligomeric structures.
Hinostroza F; Neely A; Araya-Duran I; Marabolí V; Canan J; Rojas M; Aguayo D; Latorre R; González-Nilo FD; Cárdenas AM
Sci Rep; 2020 Oct; 10(1):18151. PubMed ID: 33097808
[TBL] [Abstract][Full Text] [Related]
25. Isoform and splice-variant specific functions of dynamin-2 revealed by analysis of conditional knock-out cells.
Liu YW; Surka MC; Schroeter T; Lukiyanchuk V; Schmid SL
Mol Biol Cell; 2008 Dec; 19(12):5347-59. PubMed ID: 18923138
[TBL] [Abstract][Full Text] [Related]
26. Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy.
Gómez-Oca R; Edelweiss E; Djeddi S; Gerbier M; Massana-Muñoz X; Oulad-Abdelghani M; Crucifix C; Spiegelhalter C; Messaddeq N; Poussin-Courmontagne P; Koebel P; Cowling BS; Laporte J
Nat Commun; 2022 Nov; 13(1):6849. PubMed ID: 36369230
[TBL] [Abstract][Full Text] [Related]
27. Mutations in dynamin 2 cause dominant centronuclear myopathy.
Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
[TBL] [Abstract][Full Text] [Related]
28. Dynamin-2 in nervous system disorders.
González-Jamett AM; Haro-Acuña V; Momboisse F; Caviedes P; Bevilacqua JA; Cárdenas AM
J Neurochem; 2014 Jan; 128(2):210-23. PubMed ID: 24102355
[TBL] [Abstract][Full Text] [Related]
29. Dynamin-2 Regulates Postsynaptic Cytoskeleton Organization and Neuromuscular Junction Development.
Lin SS; Hsieh TL; Liou GG; Li TN; Lin HC; Chang CW; Wu HY; Yao CK; Liu YW
Cell Rep; 2020 Oct; 33(4):108310. PubMed ID: 33113375
[TBL] [Abstract][Full Text] [Related]
30. Dynamin 2-related centronuclear myopathy: clinical, histological and genetic aspects of further patients and review of the literature.
Jeub M; Bitoun M; Guicheney P; Kappes-Horn K; Strach K; Druschky KF; Weis J; Fischer D
Clin Neuropathol; 2008; 27(6):430-8. PubMed ID: 19130742
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
[TBL] [Abstract][Full Text] [Related]
32. Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.
Böhm J; Biancalana V; Dechene ET; Bitoun M; Pierson CR; Schaefer E; Karasoy H; Dempsey MA; Klein F; Dondaine N; Kretz C; Haumesser N; Poirson C; Toussaint A; Greenleaf RS; Barger MA; Mahoney LJ; Kang PB; Zanoteli E; Vissing J; Witting N; Echaniz-Laguna A; Wallgren-Pettersson C; Dowling J; Merlini L; Oldfors A; Bomme Ousager L; Melki J; Krause A; Jern C; Oliveira AS; Petit F; Jacquette A; Chaussenot A; Mowat D; Leheup B; Cristofano M; Poza Aldea JJ; Michel F; Furby A; Llona JE; Van Coster R; Bertini E; Urtizberea JA; Drouin-Garraud V; Béroud C; Prudhon B; Bedford M; Mathews K; Erby LA; Smith SA; Roggenbuck J; Crowe CA; Brennan Spitale A; Johal SC; Amato AA; Demmer LA; Jonas J; Darras BT; Bird TD; Laurino M; Welt SI; Trotter C; Guicheney P; Das S; Mandel JL; Beggs AH; Laporte J
Hum Mutat; 2012 Jun; 33(6):949-59. PubMed ID: 22396310
[TBL] [Abstract][Full Text] [Related]
33. [The dynamin-2-gene related centronuclear myopathy].
Bitoun M
Med Sci (Paris); 2023 Nov; 39 Hors série n° 1():6-10. PubMed ID: 37975763
[TBL] [Abstract][Full Text] [Related]
34. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation.
Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP
Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779
[TBL] [Abstract][Full Text] [Related]
35. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China.
Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q
Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959
[TBL] [Abstract][Full Text] [Related]
36. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
[TBL] [Abstract][Full Text] [Related]
37. Hepatocytes internalize trophic receptors at large endocytic "Hot Spots".
Cao H; Krueger EW; McNiven MA
Hepatology; 2011 Nov; 54(5):1819-29. PubMed ID: 21793030
[TBL] [Abstract][Full Text] [Related]
38. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
[TBL] [Abstract][Full Text] [Related]
39. Gain-of-Function Properties of a Dynamin 2 Mutant Implicated in Charcot-Marie-Tooth Disease.
Tassin TC; Barylko B; Hedde PN; Chen Y; Binns DD; James NG; Mueller JD; Jameson DM; Taussig R; Albanesi JP
Front Cell Neurosci; 2021; 15():745940. PubMed ID: 34744632
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.
Cowling BS; Toussaint A; Amoasii L; Koebel P; Ferry A; Davignon L; Nishino I; Mandel JL; Laporte J
Am J Pathol; 2011 May; 178(5):2224-35. PubMed ID: 21514436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
